Last updated: July 12, 2022
Sponsor: West China Hospital
Overall Status: Active - Recruiting
Phase
2/3
Condition
Hemorrhoids
Ulcerative Colitis (Pediatric)
Rectal Disorders
Treatment
N/AClinical Study ID
NCT05406882
HX-H2112345
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- locally advanced rectal adenocarcinoma diagnosed by histopathology; clinical stageT3/4 or N+(AJCC,8th), no metastasis; and planned to receive preoperative neoadjuvantconcurrent chemoradiotherapy.
- without other malignant tumors;
- Those without serious heart, liver, kidney and other diseases;
- ECOG score: 0-1.
Exclusion
Exclusion Criteria:
- Complicated with ulcerative colitis or Crohn's disease;
- Complicated with severe organ insufficiency, severe diabetes, and heart disease;
- Pregnant and lactating women;
- Abnormal bowel movements with systemic and metabolic diseases;
- The patient has a history of using systemic antibiotics and intestinal active bacteriain the past 1 month.
Study Design
Total Participants: 176
Study Start date:
April 15, 2022
Estimated Completion Date:
September 30, 2024
Connect with a study center
West China Hospital
Chengdu, Sichuan 610041
ChinaActive - Recruiting
Xin Wang
Chengdu, Sichuan 610041
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.